Home › Funds › Tri Locum Partners LP › RVMD
Tri Locum Partners LP position in RVMD
REVOLUTION MEDICINES INC · Health Care
Tri Locum Partners LP reported holding 40,019 shares of RVMD (REVOLUTION MEDICINES INC) in its Q3 2026 13F filing — a position valued at US$8.2M, representing 1.62% of its reported portfolio and ranking #16 among its reported holdings. Tri Locum Partners LP has disclosed RVMD holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Tri Locum Partners LP's RVMD position evolved
Tri Locum Partners LP first disclosed a stake in RVMD in Q2 2026 at 151,822 shares (US$28.4M). Across 2 filings, Tri Locum Partners LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 40,019 shares valued at US$8.2M — a reduction of -111,803 shares quarter over quarter.. Notable position changes include a 74% trim in Q3 2026 (shares fell 16% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 151.82K | $28.43M | New |
| Q3 2026 | 40.02K | $8.21M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About RVMD and 13F data
RVMD (REVOLUTION MEDICINES INC) is a Health Care company. 55 other funds we track also report a position in RVMD — the largest reported positions include FARALLON CAPITAL MANAGEMENT, L.L.C. (US$2.75B), Farallon Capital Management (US$2.54B), BAKER BROS. ADVISORS LP (US$2.14B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding RVMD
- FARALLON CAPITAL MANAGEMENT, L.L.C. 13.42M sh · $2.75B · Q3 2026
- Farallon Capital Management 13.55M sh · $2.54B · Q2 2026
- BAKER BROS. ADVISORS LP 11.44M sh · $2.14B · Q2 2026
- Darwin Global Management, Ltd. 10.63M sh · $2.05B · Q2 2026
- Nextech Invest Ltd. 7.60M sh · $1.42B · Q2 2026
- Paradigm Biocapital Advisors LP 6.22M sh · $1.28B · Q3 2026
- Janus Henderson Group 9.77M sh · $949.54M · Q1 2026
- BVF INC/IL 2.97M sh · $555.32M · Q2 2026
- Alphabet Inc. 2.67M sh · $548.85M · Q3 2026
- Casdin Capital 2.58M sh · $482.68M · Q2 2026
- Assenagon Asset Management S.A. 2.18M sh · $447.71M · Q3 2026
- Avoro Capital Advisors LLC 2.15M sh · $440.28M · Q3 2026
More on Tri Locum Partners LP
FAQ
How long has Tri Locum Partners LP held RVMD?
Tri Locum Partners LP has disclosed RVMD holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Tri Locum Partners LP's current position in RVMD?
As of Q3 2026, Tri Locum Partners LP holds 40.02K shares of RVMD (REVOLUTION MEDICINES INC), valued at $8.21M, representing 1.62% of its reported portfolio and ranking #16.
Has Tri Locum Partners LP been buying or selling RVMD?
In the latest 13F filing (Q3 2026), Tri Locum Partners LP reduced its position in RVMD.
Which other funds hold RVMD?
Other major institutional holders of RVMD include FARALLON CAPITAL MANAGEMENT, L.L.C., Farallon Capital Management, BAKER BROS. ADVISORS LP, among 55 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.